Conversely, in breast cancer, the AVKA (Thr599Ala/Ser602Ala) mutation prevents the phosphorylation of Thr599 and Ser602 of B-RAF, which enhances the invasive capacity and metastasis potential of the tumor cells [154]. This evidence concerns the gene BRAF and neoplasm.